COVID pill S-217622 shows rapid clearance of virus: Shionogi Ruchika Sharma25 April 2022 10:00 AM ISTThe company has global aspirations for the antiviral pill, which is now being evaluated by Japanese regulators.
Pfizer COVID drug Paxlovid strongly recommended by WHO Ruchika Sharma22 April 2022 1:32 PM ISTThe WHO recommended Paxlovid over remdesivir, as well as over Merck's molnupiravir pill and monoclonal antibodies.
Analysis: Demand for Pfizer COVID drug Paxlovid lags around world Ruchika Sharma21 April 2022 9:30 AM ISTPaxlovid was expected to be a major tool in the fight against COVID after it reduced hospitalizations or deaths in high-risk patients by around 90 %...
Pfizer to send 7 lakh units of COVID drug Paxlovid to Taiwan Ruchika Sharma12 April 2022 1:10 PM ISTHealth Minister Chen Shih-chung said the pills ordered would be enough to cover 3 percent of Taiwan's population, with half of them due to arrive in...
GST for COVID drugs pegged at 5 percent, says Govt Ruchika Sharma5 April 2022 10:30 AM ISTNew Delhi: COVID-19 medicines and instruments are being sold at a GST rate of five per cent while other medicines are sold at a GST rate between five...
ED files charge sheet in Remdesivir black marketing case MD Bureau5 April 2022 9:00 AM ISTNew Delhi: The Enforcement Directorate (ED) on Monday said that they have filed a prosecution complaint (charge sheet) against Rahul Bardhan, Biswajit...
UK study to test Pfizer COVID drug Paxlovid in hospitalised patients Ruchika Sharma31 March 2022 9:45 AM ISTRecovery, led by the University of Oxford, will probe whether Paxlovid shortens the length of hospital stay or reduces the need for a mechanical...
Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Hetero COVID drug Molnupiravir shows positive results in Phase III trials Ruchika Sharma21 Feb 2022 4:37 PM ISTHyderabad: Hetero, a globally renowned vertically integrated pharmaceutical organization has recently announced the positive results of Phase III...
Pfizer COVID drug Paxlovid gets conditional approval in China Ruchika Sharma14 Feb 2022 11:59 AM ISTNew Delhi: China's medical products regulator said on saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the...
